Inventor · disambiguated record
Kenechi Ejebe
Also filed as: EJEBE KENECHI
20 granted patents·15 pending applications·1,062 citations·filing 2011–2024
97Inventor score
Top patents by PatentIndex Score
35 records- 0199US10772975B2Modified Polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2017·Granted Sep 15, 2020·37 cites·11 claims
- 0299US10064959B2Modified nucleosides, nucleotides, and nucleic acids, and uses thereofMODERNATX INC·Filed 2017·Granted Sep 4, 2018·45 cites·30 claims
- 0399US9657295B2Modified nucleosides, nucleotides, and nucleic acids, and uses thereofMODERNA THERAPEUTICS INC·Filed 2016·Granted May 23, 2017·46 cites·20 claims
- 0499US9587003B2Modified polynucleotides for the production of oncology-related proteins and peptidesMODERNA THERAPEUTICS INC·Filed 2016·Granted Mar 7, 2017·67 cites·19 claims
- 0599US9572896B2In vivo production of proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Feb 21, 2017·75 cites·11 claims
- 0699US9572897B2Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteinsMODERNA THERAPEUTICS INC·Filed 2016·Granted Feb 21, 2017·65 cites·19 claims
- 0799US9504734B2Modified polynucleotides for the production of nuclear proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Nov 29, 2016·56 cites·19 claims
- 0899US9334328B2Modified nucleosides, nucleotides, and nucleic acids, and uses thereofMODERNA THERAPEUTICS INC·Filed 2013·Granted May 10, 2016·110 cites·10 claims
- 0999US9254311B2Modified polynucleotides for the production of proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Feb 9, 2016·126 cites·14 claims
- 1099US9221891B2In vivo production of proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Dec 29, 2015·113 cites·13 claims
- 1198US8999380B2Modified polynucleotides for the production of biologics and proteins associated with human diseasemodeRNA Therapeutics·Filed 2013·Granted Apr 7, 2015·258 cites·16 claims
- 1297US12357708B2Modified nucleosides, nucleotides, and nucleic acids, and uses thereofMODERNATX INC·Filed 2024·Granted Jul 15, 2025·1 cites·1 claims
- 1397US9814760B2Modified polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2015·Granted Nov 14, 2017·15 cites·12 claims
- 1496US9782462B2Modified polynucleotides for the production of proteins associated with human diseaseMODERNA THERAPEUTICS INC·Filed 2016·Granted Oct 10, 2017·7 cites·19 claims
- 1596US9447164B2Engineered nucleic acids and methods of use thereofMODERNA THERAPEUTICS INC·Filed 2015·Granted Sep 20, 2016·15 cites·13 claims
- 1695US9937233B2Engineered nucleic acids and methods of use thereofMODERNATX INC·Filed 2016·Granted Apr 10, 2018·12 cites·34 claims
- 1795US9827332B2Modified polynucleotides for the production of proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Nov 28, 2017·7 cites·33 claims
- 1891US9828416B2Modified polynucleotides for the production of secreted proteinsMODERNATX INC·Filed 2015·Granted Nov 28, 2017·3 cites·24 claims
- 1991US9701965B2Engineered nucleic acids and methods of use thereofMODERNATX INC·Filed 2014·Granted Jul 11, 2017·4 cites·16 claims
- 2087US12496358B2Modified nucleosides, nucleotides, and nucleic acids, and uses thereofMODERNATX INC·Filed 2022·Granted Dec 16, 2025·0 cites·1 claims
- 2181US2021115101A1Modified polynucleotides for the production of proteins associated with human diseaseMODERNATX INC·Filed 2019·Application pending·0 cites
- 2279US2022273766A1Engineered nucleic acids and methods of use thereofMODERNATX INC·Filed 2021·Application pending·0 cites
- 2379US2021299278A1Modified polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2020·Application pending·0 cites
- 2476US2021236655A1Engineered Nucleic Acids and Methods of Use ThereofMODERNATX INC·Filed 2020·Application pending·0 cites
- 2572US2018086807A1Modified polynucleotides for the production of proteins associated with human diseaseMODERNATX INC·Filed 2017·Application pending·0 cites
- 2672US2019160185A1Modified nucleosides, nucleotides, and nucleic acids, and uses thereofMODERNATX INC·Filed 2018·Application pending·0 cites
- 2771US2019240351A1Modified polynucleotides for the production of proteinsMODERNATX INC·Filed 2017·Application pending·0 cites
- 2870US2018112221A1Engineered Nucleic Acids and Methods of Use ThereofMODERNATX INC·Filed 2017·Application pending·0 cites
- 2969US2018170990A1Modified polynucleotides for the production of nuclear proteinsMODERNATX INC·Filed 2017·Application pending·0 cites
- 3067US2017028085A1Modified polynucleotides for the production of nuclear proteinsMODERNATX INC·Filed 2016·Application pending·0 cites
- 3166US2013244282A1Method of producing antibodiesmodeRNA Therapeutics·Filed 2013·Application pending·0 cites
- 3265US2012237975A1Engineered nucleic acids and methods of use thereofSCHRUM JASON·Filed 2011·Application pending·0 cites
- 3365US2019030129A1Engineered nucleic acids and methods of use thereofMODERNATX INC·Filed 2018·Application pending·0 cites
- 3456US2022273555A1Modified polynucleotides for the production of membrane proteinsMODERNATX INC·Filed 2020·Application pending·0 cites
- 3542US2016289674A1Modified polynucleotides for the production of membrane proteinsMODERNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kenechi Ejebe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →